https://www.avient.com/sites/default/files/2023-02/AVNT Q4 2022 Earnings Presentation.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources. Avient reflects 2023 adjusted EBITDA guidance of $530M and estimated run-rate CAPEX of $110M. Avient Specialty Other Specialty / 2023E(%) 28 79 87 81 79 76 73 90 77 76 75 73 64 59 33 MULTIPLE EXPANSION Avient Specialty Other Specialty / Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.